QSS
PETX

Quantitative Systematic Strategies’s Aratana Therapeutics, Inc. PETX Stock Holding History

Quantitative Systematic Strategies’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,418
Closed -$95K – 776
2018
Q4 		$95K Buy
+15,418
New +$94.1K 0.02% 613

Other funds holding PETX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Quantitative Systematic Strategies's PETX Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2019, closing a stake of 15,418 shares — an estimated $95K sold.

Quantitative Systematic Strategies first reported a position in PETX in Q4 2018 and held it in 1 quarter. The position peaked at $95K in Q4 2018. 104 funds tracked by Wall St. Rank hold PETX as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining Aratana Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 15,418 Aratana Therapeutics, Inc. shares in Q1 2019, an estimated $95K.
  • Quantitative Systematic Strategies first reported a position in Aratana Therapeutics, Inc. in Q4 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Aratana Therapeutics, Inc. position peaked at $95K in Q4 2018.
  • 104 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.